Skip to content
Saturday, November 14, 2026
Britprize Media

Users Coming Off Slimming Jabs Regain Pounds Far More Rapidly Compared to Dieters

Image of pharmaceutical injection and scale
Obesity treatment involves ongoing approaches.

Fresh analysis reveals that patients who stop using new weight-loss injections like semaglutide or tirzepatide tend to recover reduced body mass at a significantly accelerated pace than those who halt conventional lifestyle regimens.

Findings released in a leading medical journal points out that while obese people frequently drop substantial amounts of their total mass while undergoing treatment, the weight comes back at an estimated rate of 0.8 kg per month upon discontinuation.

"Users purchasing such drugs must be cognizant of the risk of fast weight regain when the therapy ends," warns lead investigator Dr. Susan Jebb.

That rate of recovery suggests a return to starting weight within about a year and a half.

Analyzing Approaches

The analysis, which looked at 37 of trials involving thousands of patients, contrasted the effects of these new drugs with older methods.

Scientists emphasize that people who lose weight through lifestyle changes alone typically experience a less rapid creep back—around 0.1 kg a month—once they finish.

The Reason for the Quick Regain

Experts suggest the mechanism of the jabs explains the amplified regain.

These medications copy a natural hormone called GLP-1, which helps regulate hunger.

"Sustained high doses of the hormone levels far above than normal may cause the body to produce less of its endogenous hormone, and could reduce sensitivity to its effects," explained Dr. Adam Collins, a dietetics expert.

"Stopping of this medication leads to hunger is unsuppressed, making overeating a significant risk."

A Chronic Condition?

Health authorities suggest the injections for individuals with obesity-related medical conditions, alongside recommended diet and exercise modifications.

A number of clinicians contend that, given the significant potential of relapse, the treatment is often long-term.

This opinion is reinforced by pharmaceutical companies, who note that the results "emphasize the persistent character of excess weight," similar to managing conditions like high blood pressure.

Patient Accounts

People who have stopped the medication report a sudden resurgence of appetite.

"It was like something flipping and you're instantly extremely hungry," said one woman.

This difficulty is worsened if users have not developed permanent lifestyle or habit modifications during therapy.

Widespread Use

Survey data suggest that a significant number of people in the UK have used weight-loss jabs in the past year, with demand continuing to grow.

  • Use is greater among females compared to men.
  • The middle-aged demographic shows the greatest usage rates.
  • Many access the medications through private healthcare rather than the NHS.

In conclusion, clinicians caution that while these medications are potent tools for weight loss, they are not a standalone fix and long-term success hinges on combined lifestyle management.

JS
The writer

Jason Sanders

Eleanor Vance is a digital marketing strategist with over a decade of experience in SEO and content creation, helping businesses achieve measurable growth.

Britprize Media

Type to search articles.